Explorer les evidences

25 %The frequency of HBeAg among HIV/HBV co-infected cohort was 25%.

Nigeriahépatite B · HIV/HBV co-infectionpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 11 observations

7,4 %The prevalence of Hepatitis B surface antigenemia (HBsAg) positivity among pregnant women in Jos, Nigeria was 7.4% (241 out of 3,238) between November 1, 2017 and April 30, 2018.

Nigeriahépatite Bobservé November 1, 2017 to April 30, 2018publié 2020Annals of African medicinePubMeddocument de 5 observations

14,9 %Chronic hepatitis B infection was the most prevalent complication, seen in 14.9% of the children.

Nigeriadrépanocytose · hépatite Bpublié 2021West African journal of medicinePubMeddocument de 10 observations

2,23 %The overall prevalence of HBV among full-time, newly admitted undergraduate university students in Southwestern Nigeria between 2015 and 2017 was 2.23%.

Nigeriahépatite Bobservé 2015 and 2017publié 2023The Pan African medical journalPubMeddocument de 2 observations

8,1 %HBV prevalence in Nigeria was 8.1%.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

0,8 %Among 265 livestock handlers in Ibadan, Nigeria, 2 (0.8%) were coinfected with HIV and HBV.

Nigeriahépatite B · VIH/sidaobservé October 2016 to April 2017publié 2024African health sciencesPubMeddocument de 5 observations

In this study, HBV genotype E was the most frequently identified genotype among asymptomatic carriers in Nigeria.

Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations

0,64 %Among HIV-positive patients in the study, the prevalence of HIV/HBV/HCV triple infection was 0.64% among females and 0% among males.

Nigeriahépatite B · hépatite C · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

62 %In this study, the classical precore G1896A variant was identified in 26 out of 42 (62%) asymptomatic carriers.

Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations

33,2 %33.2% of participants had detectable HBV viral loads ≥300 copies/mL.

Nigeriahépatite Bobservé 2018publié 2025Pathogens (Basel, Switzerland)PubMeddocument de 8 observations

800 000 deathsHepatitis B virus accounts for mortality of about 800,000 from liver cirrhosis and hepatocellular carcinoma.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 11 observations

81 %In this study, 34 out of 42 (81%) asymptomatic carriers had the C1741T mutation in the BCP region.

Nigeriahépatite Bpublié 2025Viruseseurope_pmcdocument de 6 observations

4,7 %Hepatitis B seropositivity was observed in 62 (4.7%) of 1329 patients enrolled for haemodialysis between 2019 and 2022 in four public dialysis centres in Kano and Jigawa state, Northwest Nigeria.

Nigeriahépatite Bobservé 2019–2022publié 2023The Nigerian postgraduate medical journalPubMeddocument de 10 observations

No evidence of HBV infection was observed in women with a history of HBV vaccination.

Nigeriahépatite Bpublié 2021Journal of environmental and public healthPubMeddocument de 4 observations

0,12 %Among 2386 initially uninfected pregnant women in Nigeria followed until delivery, the seroconversion rate for HIV-HBV dual infection was 0.12%.

Nigeriahépatite B · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations

3,85 %Among pregnant women without formal education in Ejule Metropolis, the prevalence of HBV infection was 3.85%.

Nigeriahépatite Bpublié 2021Journal of environmental and public healthPubMeddocument de 4 observations

11,8 %Among PLHIV aged 51–60 years, the prevalence of HBeAg was 11.8%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

13,9 %Among male PLHIV participants, the prevalence of HBsAg was 13.9%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

2 %The seroprevalence of hepatitis B infection among HIV-infected children and young adults in Calabar, Nigeria was 2%.

Nigeriahépatite Bpublié 2024Journal of infection in developing countriesPubMeddocument de 5 observations

38,5 %The prevalence of BCP double substitution A1762T was 38.5% among sequenced BCP/PC gene amplicons.

Nigeriahépatite Bpublié 2023Viruseseurope_pmcdocument de 6 observationsDOI 10.3390/v15112188

7,2 %Among pregnant women in Jos, Nigeria, the prevalence of hepatitis B virus (HBV) was 7.2% among those without human immunodeficiency virus (HIV), during the period from 1 November 2017 to 30 April 2018.

Nigeriahépatite B · VIH/sidaobservé 1 November 2017 to 30 April 2018publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 3 observations

3,85 %Among HIV-positive patients in the study, the prevalence of HIV/HBV co-infection was 3.85% among females and 2.57% among males.

Nigeriahépatite B · VIH/sidaobservé 2019publié 2020Journal of immunoassay & immunochemistryPubMeddocument de 9 observations

9,8 %Among PLHIV aged 31–40 years, the prevalence of anti-HBe was 9.8%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations

0,6 %Dual seropositivity of anti-hepatitis C virus/hepatitis B surface antigen among pregnant women in Nigeria accounted for 0.6%.

Nigeriahépatite B · hépatite Cpublié 2021Women's health (London, England)PubMeddocument de 7 observations

8,7 %The prevalence of HBsAg among 150 PLHIV in the study was 8.7%.

Nigeriahépatite Bpublié 2021Journal of immunoassay & immunochemistryPubMeddocument de 15 observations